Dr. Valentyn Tyulmenkov, MD

Dr. Tyulmenkov practices at Broward Health Medical Center in Fort Lauderdale, Florida, part of North Broward Hospital District.

Dr. Tyulmenkov's NPI, 1548269178, was assigned on July 15, 2005. Dr. Tyulmenkov graduated from Crimea State Medical University in 1985. Dr. Tyulmenkov's Kentucky license number on file is 38490.

Dr. Tyulmenkov's primary practice is Broward Health Medical Center, at 1600 S Andrews Ave, Fort Lauderdale, FL 33316 in Broward County. The practice phone is (954) 355-4400.

Dr. Tyulmenkov's primary practice is Broward Health Medical Center in Fort Lauderdale, Florida, part of North Broward Hospital District. Dr. Tyulmenkov is also affiliated with Methodist Hospital. The medical group on file is Florida Hospital Medicine Services, Llc. Dmand AI also links Dr. Tyulmenkov to 3 more hospitals, 7 medical groups, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tyulmenkov practices, 7 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Tyulmenkov's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Tyulmenkov is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tyulmenkov's licenses on file in 8 states: Kentucky, Texas, Florida, Tennessee, Indiana, Ohio, Georgia and Oklahoma.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, bile duct problems, cardiac arrhythmia, circulatory problems in extremities, cirrhosis and collapsed lung among the conditions Dr. Tyulmenkov treats.

CMS data shows 857 Medicare services from Dr. Tyulmenkov across 5 procedure codes in 2024, for 330 Medicare patients. Medicare paid $68,687 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 330 Medicare patients who saw Dr. Tyulmenkov in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tyulmenkov's median patient age at 66, with 53% women.

In 2024, Dr. Tyulmenkov wrote 606 Medicare Part D claims for 249 patients. 88% of them were for generic drugs. CMS names the drug for 281 of them, across 16 drugs with 11 or more claims each, at $9,169 in total drug cost. In 2023, CMS named 232 claims across 13 drugs.

Dr. Tyulmenkov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Tyulmenkov. The most frequent topics are Estrogen Receptor alpha, Genes, Reporter and Receptors, Estrogen. Dr. Tyulmenkov has published most often in Mol Cell Endocrinol. Dr. Tyulmenkov's most frequent co-author is Sarah Crissey Jernigan, MD.

CMS Open Payments shows 8 general payments to Dr. Tyulmenkov from 5 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $115.

Dr. Tyulmenkov graduated from Crimea State Medical University in 1985.

Dr. Tyulmenkov is in network with 21 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.